» Articles » PMID: 36608055

A Proteomic Perspective and Involvement of Cytokines in SARS-CoV-2 Infection

Overview
Journal PLoS One
Date 2023 Jan 6
PMID 36608055
Authors
Affiliations
Soon will be listed here.
Abstract

Infection with the SARS-CoV-2 virus results in manifestation of several clinical observations from asymptomatic to multi-organ failure. Biochemically, the serious effects are due to what is described as cytokine storm. The initial infection region for COVID-19 is the nasopharyngeal/oropharyngeal region which is the site where samples are taken to examine the presence of virus. We have now carried out detailed proteomic analysis of the nasopharyngeal/oropharyngeal swab samples collected from normal individuals and those tested positive for SARS-CoV-2, in India, during the early days of the pandemic in 2020, by RTPCR, involving high throughput quantitative proteomics analysis. Several proteins like annexins, cytokines and histones were found differentially regulated in the host human cells following SARS-CoV-2 infection. Genes for these proteins were also observed to be differentially regulated when their expression was analyzed. Majority of the cytokine proteins were found to be up regulated in the infected individuals. Cell to Cell signaling interaction, Immune cell trafficking and inflammatory response pathways were found associated with the differentially regulated proteins based on network pathway analysis.

Citing Articles

Exploration of phosphoproteomic association during epimorphic regeneration.

Banu S, Anusha P, Mandal K, Idris M Sci Rep. 2025; 15(1):4854.

PMID: 39924536 PMC: 11808059. DOI: 10.1038/s41598-024-84735-z.


Utility of Protein Markers in COVID-19 Patients.

Alicia L, Maria Angeles O, Desiree M, Maximino R, Marilina G Int J Mol Sci. 2025; 26(2).

PMID: 39859366 PMC: 11766239. DOI: 10.3390/ijms26020653.


Proteomics: Unraveling the Cross Talk Between Innate Immunity and Disease Pathophysiology, Diagnostics, and Treatment Options.

Luz I, Takaya R, Ribeiro D, Castro M, Fontes W Adv Exp Med Biol. 2024; 1443:221-242.

PMID: 38409424 DOI: 10.1007/978-3-031-50624-6_12.


Macrophage-Derived Chemokine MDC/CCL22: An Ambiguous Finding in COVID-19.

Korobova Z, Arsentieva N, Totolian A Int J Mol Sci. 2023; 24(17).

PMID: 37685890 PMC: 10487728. DOI: 10.3390/ijms241713083.

References
1.
Kong D, Kim Y, Kim M, Jang J, Lee S . Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer. Int J Mol Sci. 2018; 19(4). PMC: 5979609. DOI: 10.3390/ijms19041057. View

2.
Sitaram N, Nagaraj R . Interaction of antimicrobial peptides with biological and model membranes: structural and charge requirements for activity. Biochim Biophys Acta. 1999; 1462(1-2):29-54. DOI: 10.1016/s0005-2736(99)00199-6. View

3.
Villar M, Urra J, Rodriguez-Del-Rio F, Artigas-Jeronimo S, Jimenez-Collados N, Ferreras-Colino E . Characterization by Quantitative Serum Proteomics of Immune-Related Prognostic Biomarkers for COVID-19 Symptomatology. Front Immunol. 2021; 12:730710. PMC: 8457011. DOI: 10.3389/fimmu.2021.730710. View

4.
Ghalib Enayathullah M, Parekh Y, Banu S, Ram S, Nagaraj R, Kumar B . Gramicidin S and melittin: potential anti-viral therapeutic peptides to treat SARS-CoV-2 infection. Sci Rep. 2022; 12(1):3446. PMC: 8891299. DOI: 10.1038/s41598-022-07341-x. View

5.
Abbas M, Verma S, Verma S, Siddiqui S, Khan F, Raza S . Association of GSTM1 and GSTT1 gene polymorphisms with COVID-19 susceptibility and its outcome. J Med Virol. 2021; 93(9):5446-5451. PMC: 8242761. DOI: 10.1002/jmv.27076. View